Pharma CRAMS Research in India
Wednesday, July 09, 2008
Indian Pharma companies are now moving up the value chain with the ultimate goal to become global R&D hubs in-line with the Governmnet's vision to make India a Global Knowledge Center. Leading Pharmaceutical Companies in CRAMs (Contract Research and Manufacturing Services) segment - Biocon, Dishman Pharmaceuticals, Jubilant Organosys and Piramal Healthcare. In the current scenario, the outlook for CRAMs companies remain robust as the R&D productivity of global pharmaceutical companies is constantly declining and ever increasing costs for discovering new molecules, will force these companies to reduce costs and improve productivity. Consequently they are forced to shift some of their manufacturing activity to the low cost labour intensive countries like India which offer both quality and cost advantage.
Various Research including that of KPMG indicate that the global opportunity in Contract Manufacturing and Research are pegged at ~USD 21 bn and at ~USD 14 bn, respectively.
0 Comments:
Dalal Street Business Reports
- Indian Macro under Pressure - Capital Goods Downgr...
- Great Eastern Shipping - Initiating Coverage
- Indian Markets - Short Term Pain, Long Term Gain
- DLF on a Buy Back Saga to Boost Stock Price
- Year to Date Performance of Indian Indices
- Caution on Indian Banks - Morgan Stanley
- How to Calculate SENSEX Earnings / EPS ?
- Indian Party Spolied for Sure, But Not Over
- Emco + Crompton Greaves to Transform your Portfoli...
- United Spirits - Mallya running out of spirit
